Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Conditions
Interventions
tonapofylline
Placebo
Locations
189
United States
Huntsville, Alabama, United States
Mobile, Alabama, United States
Fort Smith, Arkansas, United States
Beverly Hills, California, United States
Chula Vista, California, United States
Mission Viejo, California, United States
Start Date
July 31, 2008
Primary Completion Date
October 30, 2009
Completion Date
December 31, 2009
Last Updated
September 11, 2023
NCT07262333
NCT01524276
NCT05507879
NCT04551560
NCT07101289
NCT07203131
Lead Sponsor
Biogen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions